- Patent Title: Composition and method to enhance expression of human defensin 2
-
Application No.: US15798848Application Date: 2017-10-31
-
Publication No.: US10653714B2Publication Date: 2020-05-19
- Inventor: Carol de la Motte , Sean Kessler , David Richard Hill
- Applicant: THE CLEVELAND CLINIC FOUNDATION
- Applicant Address: US OH Cleveland
- Assignee: The Cleveland Clinic Foundation
- Current Assignee: The Cleveland Clinic Foundation
- Current Assignee Address: US OH Cleveland
- Agency: Barnes & Thornburg LLP
- Main IPC: A61K31/728
- IPC: A61K31/728 ; A23L33/10 ; A23L33/19 ; A61K47/61 ; A61K47/64 ; A61K38/40 ; A61K9/127
Abstract:
Compositions and methods are provided for enhancing the expression of human beta defensin 2 (HBD2) in human colon epithelium cells. The method comprises orally administering a composition comprising hyaluronan, where said hyaluronan has a molecular weight within the range of about 35 kDa.
Public/Granted literature
- US20180117078A1 COMPOSITION AND METHOD TO ENHANCE EXPRESSION OF HUMAN DEFENSIN 2 Public/Granted day:2018-05-03
Information query
IPC分类:
